Patent holdings for IPC class A61K 31/41

Total number of patents in this class: 2826

10-year publication summary

167
202
181
170
165
162
157
142
124
59
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Novartis AG
10927
81
SK Biopharmaceuticals Co., Ltd.
261
74
Merck Sharp & Dohme Corp.
2201
44
Bristol-myers Squibb Company
4897
39
Allergan, Inc.
2359
34
Merck Sharp & Dohme LLC
3739
34
The Regents of the University of California
19803
25
Boehringer Ingelheim International GmbH
4701
25
F. Hoffmann-La Roche AG
7920
23
AstraZeneca AB
2928
17
Shenzhen Salubris Pharmaceuticals Co., Ltd
90
16
Scandion Oncology A/S
26
16
Centre National de La Recherche Scientifique
10311
15
Bayer Pharma AG
1061
15
The Johns Hopkins University
5637
15
Genentech, Inc.
3954
14
The General Hospital Corporation
4701
14
Boryung Pharmaceutical Co., Ltd.
63
14
Theravance Biopharma R&D IP, LLC
462
14
Rigel Pharmaceuticals, Inc.
541
13
Other owners 2284